Digital health startups don’t fail because of bad technology.

They fail because commercialization is treated as an afterthought.

TransPharMed is a Commercialization Lab built exclusively for digital health startups that need to turn innovation into predictable revenue.

We help founders move from vision to commercial discipline using our structured PROS Framework:

Prep – Clarify positioning, ideal buyer, stakeholder map, and enterprise value narrative
Rev – Design revenue architecture, pricing strategy, sales process, and pipeline discipline
Ops – Build execution systems, enable sales teams, reduce cycle waste, and improve capital efficiency
Signals – Interpret market shifts, regulatory changes, and buyer behavior to guide strategic pivots

Before scaling, we deploy our Commercial Readiness Audit — a rigorous diagnostic that evaluates product complexity, buyer complexity, sales friction, proof-of-value readiness, and enterprise integration risk.

The result?
Founders gain objective clarity on whether they are truly ready to scale — or simply hoping they are.

We also power the Digital Health Sales Institute (DHSI), training commercial talent to sell effectively into providers, payers, pharma, and government systems. Because scaling revenue requires professionals who understand healthcare complexity — not generic SaaS playbooks.

We work with Seed to Series B digital health startups selling into enterprise healthcare environments.

If your product touches health systems, payers, pharma, or government — and you are preparing to scale — we build the commercial infrastructure to support it.

Innovation creates attention.

Commercial discipline creates revenue.

TransPharMed

Org chart

Teams

Offices

TransPharMed

Org chart

Teams

Offices

Related companies